Abstract
The last decade has seen significant improve ments in the prehospital management of many medical emergencies. New therapies are being used, and there are better ways of rapidly targeting them to patients who will benefit. In this article, we discuss the implications of providing prehospital thrombolysis for acute myo cardial infarction (AMI). We examine the role that cost plays in affecting the choice of treatment, and estimate the costs to be borne by healthcare pur chasers. We conclude by examining the options for improved delivery of thrombolysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
